PTPRC and neoplasm: Indeed, Taieb et al. (2006) and others (Chan et al., 2006) described CD11cint B220+CD49b+NK1.1+MHC-II+ cells sharing both antigen presentation and cytotoxic functions culminating in anti-tumor activity (Taieb et al., 2006).